Synopsys (NASDAQ:SNPS – Free Report) had its target price reduced by Piper Sandler from $520.00 to $430.00 in a report issued on Thursday,Benzinga reports. They currently have a neutral rating on the semiconductor company’s stock.
A number of other research analysts also recently issued reports on SNPS. KeyCorp upped their price target on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price on the stock. in a research note on Friday, February 20th. Citigroup began coverage on shares of Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 price target for the company. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Finally, Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Eight research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $531.00.
Check Out Our Latest Stock Report on Synopsys
Synopsys Stock Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 7.49%. The firm had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. During the same quarter in the prior year, the company posted $3.03 earnings per share. The business’s revenue for the quarter was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Sell-side analysts expect that Synopsys will post 10.64 EPS for the current fiscal year.
Insider Activity
In other Synopsys news, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,157 shares of company stock valued at $1,945,036 in the last three months. 0.62% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Synopsys
Several large investors have recently added to or reduced their stakes in the company. Strategic Investment Solutions Inc. IL purchased a new position in shares of Synopsys during the 4th quarter valued at $326,000. Nolet Wealth Management LLC bought a new stake in Synopsys during the fourth quarter valued at about $228,000. Phillip James Consulting Co. purchased a new position in shares of Synopsys in the fourth quarter valued at about $36,000. MV Capital Management Inc. purchased a new position in shares of Synopsys in the fourth quarter valued at about $73,000. Finally, Sunbelt Securities Inc. boosted its stake in shares of Synopsys by 1,250.0% in the fourth quarter. Sunbelt Securities Inc. now owns 243 shares of the semiconductor company’s stock worth $114,000 after acquiring an additional 225 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Key Stories Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Q1 beat and AI-driven revenue surge — Synopsys reported Q1 revenue up ~65% and an EPS beat, driven by EDA demand and the Ansys deal; the results validate AI-led chip‑design tailwinds. Synopsys Q1 Earnings
- Positive Sentiment: Ansys integration expands long‑term TAM — Management and analysts highlight that combining EDA with Ansys simulation opens full‑system design markets (servers, autonomous systems), which could materially enlarge revenue opportunities over the medium term. Can AI Push in EDA & Ansys Integration?
- Positive Sentiment: Capital return and trader interest — Board approved a $2B buyback and there was high call‑option volume / large option trades, signaling bullish positioning by some traders. Those actions provide buy‑side support. Why Is Synopsys Stock Falling? Call Options Volume
- Neutral Sentiment: Analyst consensus still skewed positive, but stock has lagged peers — Wall Street average rating remains around “Buy” even as SNPS underperformed some tech peers over the past year, leaving room for divergence between sentiment and price action. How Is Synopsys’ Stock Performance Compared?
- Negative Sentiment: Guidance and China/export risks — Management flagged a muted near‑term quarter and a Q2 revenue guide that disappointed some investors; Reuters notes export restrictions to China as a headwind to visibility. Reuters: Muted Quarter
- Negative Sentiment: Integration costs, GAAP loss and IP weakness — Analysts and social commentary point to near‑term profitability pressure from Ansys deal costs, one‑time charges and workforce reductions, plus continued softness in the Design IP segment. QuiverQuant: Integration & IP Issues
- Negative Sentiment: Analyst price‑target trims — Several firms trimmed targets or moved to neutral/equal‑weight after the report (Piper Sandler, Wells Fargo, Rosenblatt adjustments), which can depress sentiment even if ratings remain constructive. Benzinga: Price Target Changes
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
